Maury Raycroft
Jefferies | Healthcare
Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector. Ranked #859 out of 4363 analysts, they have issued 9 stock ratings with a success rate of 74.59% and an average return of 44.57%.
With 9 ratings to date, Maury Raycroft is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 74.59% and an average return of 44.57%, highlighting promising potential as their track record develops further.
Recent Ratings Analysis
KZR
HoldOct 17, 2025
Target
$7.00
Current
$6.31
Performance
-0.79%
Maury Raycroft rated KZR as Hold on Oct 17, 2025, setting a price target of 7. The Hold stance appears justified, as shares hovered around 6.31 with a -0.79% move.
KOD
BuySep 22, 2025
Target
$15.00
Current
$17.70
Performance
17.92%
On Sep 22, 2025, KOD was given a Buy rating by Maury Raycroft, with a target price of 15. The stock rallied 17.92% after the rating, narrowing the gap to the target of 15 and validating the bullish stance.
ALNY
BuyJul 07, 2025
Target
$384.00
Current
$491.22
Performance
51.55%
ALNY received a Buy rating from Maury Raycroft on Jul 07, 2025, aiming for 384. Momentum has favored the Buy call, with shares climbing from 491.22 to 491.22, rewarding those who trusted the recommendation.
CRDF
HoldJun 24, 2025
Target
$3.50
Current
$2.28
Performance
-28.75%
On Jun 24, 2025, Maury Raycroft published a Hold outlook on CRDF, with a target of 3.5. Weakness in the stock, now at 2.28, supported the conservative rating.
CRBP
BuyMar 11, 2025
Target
$53.00
Current
$18.28
Performance
165.70%
Maury Raycroft on Mar 11, 2025 assigned CRBP a Buy rating, with a price target of 53. The Buy call aligned well with market performance, producing a gain of 165.70%.
CMRX
HoldMar 05, 2025
Target
$8.50
Current
$8.54
Performance
0.95%
On Mar 05, 2025, Maury Raycroft reaffirmed CMRX with a Hold rating, targeting 8.5. The neutral call matched muted market action of 0.95%.
CMPX
BuyFeb 10, 2025
Target
$8.00
Current
$4.05
Performance
3.85%
CMPX was rated Buy by Maury Raycroft on Feb 10, 2025, with a price objective of 8. The stock is in a wait-and-see zone, leaving the Buy case open-ended.
SGMO
BuyDec 31, 2024
Target
$3.00
Current
$0.68
Performance
-33.82%
On Dec 31, 2024, Maury Raycroft initiated coverage on SGMO with a Buy rating and target of 3. The Buy call has yet to be validated as shares remain 2.33 away from the target.
MREO
BuyDec 06, 2024
Target
$7.00
Current
$2.24
Performance
-40.58%
Maury Raycroft issued a Buy recommendation for MREO on Dec 06, 2024, price target set at 7. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.
ERAS
BuyNov 18, 2024
Target
$6.00
Current
$2.46
Performance
-9.89%
On Nov 18, 2024, ERAS was evaluated by Maury Raycroft, who gave a Buy rating and target of 6. Investors saw limited payoff as shares fell short of the 6 target.
TNGX
BuyJul 17, 2024
Target
$19.00
Current
$9.15
Performance
-6.25%
Maury Raycroft rated TNGX as Buy on Jul 17, 2024, setting a price target of 19. The stock has underperformed, dropping 6.25% despite the bullish target of 19.
CALT
HoldMay 28, 2024
Target
$39.00
Current
$40.00
Performance
5.40%
On May 28, 2024, CALT was given a Hold rating by Maury Raycroft, with a target price of 39. The stock rallied from 40.0001 to 40.0001 after the Hold rating, surprising to the upside.
PRME
BuyMay 07, 2024
Target
$15.00
Current
$6.18
Performance
10.95%
PRME received a Buy rating from Maury Raycroft on May 07, 2024, aiming for 15. Momentum has favored the Buy call, with shares climbing from 6.18 to 6.18, rewarding those who trusted the recommendation.